INS and diabetes mellitus: The 2025 American Diabetes Association Standards of Care in Diabetes [4] recommend quarterly hemoglobin A1c (HbA1c) testing, in addition to blood glucose monitoring and continuous glucose monitoring (CGM) for people who are treated with any type of insulin therapy.